Skip to Content
by Dagny Stuart | Monday, Jun. 11, 2012, 3:15 PM
A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
Dagny Stuart, (615) 936-7245
External Story, Health and Medicine, Reporter, Research American Association for Cancer Research, American Cancer Society, biomarker, breast cancer, Breast Cancer Research Foundation, cancer, Carlos Arteaga, chemotherapy, DNA, featured research, genes, Genetic Medicine, genetics, Justin Balko, Lee Jeans Translational Breast Cancer Research Program, NCI, NIH, personalized medicine, pharmacology, SPORE, Stand Up To Cancer, vicc
There are lots of ways to keep up with Vanderbilt. Choose your preferred method: